2026-09-18T18:56:57Zhttps://dspace.mit.edu/server/oai/requestoai:dspace.mit.edu:1721.1/1514852023-08-01T03:44:56Zcom_1721.1_7582com_1721.1_7581col_1721.1_131022
Bouma, Brett E.
Uribe-Patarroyo, Néstor
Cannon, Taylor M.
Harvard-MIT Program in Health Sciences and Technology
2023-07-31T19:43:26Z
2023-07-31T19:43:26Z
2023-06
2023-06-13T20:48:32.810Z
https://hdl.handle.net/1721.1/151485
0000-0001-5776-1079
Optical imaging offers unique advantages in medical diagnostics. In particular, high resolution, fast imaging speed, and strong depth penetration make optical coherence tomography (OCT) an attractive modality for non-perturbatively investigating structural changes in tissue that accompany disease progression on the microscale. Although clinical interpretation of OCT images is generally qualitative, the scattered light intensity signal underlying these images may be analyzed further to calculate sub-resolution sample properties, accessing additional functional information in tissue. Developing meaningful ways to compute and interpret these properties could enable earlier detection of structural disease-associated tissue changes, such as increases in sizes and densities of epithelial nuclei with the progression of esophageal dysplasia. In this thesis research, we investigate the application of novel signal processing methods and custom OCT hardware to uncover biomarkers of dysplasia based on these pathological changes in cell nuclei. Further, we apply our methods to evaluate patients during upper gastrointestinal endoscopy using a custom imaging device designed for enhanced sensitivity to these dysplastic changes, potentiating a more sensitive screening paradigm towards earlier detection of esophageal cancer.
Ph.D.
Massachusetts Institute of Technology
In Copyright - Educational Use Permitted
Copyright retained by author(s)
https://rightsstatements.org/page/InC-EDU/1.0/
Volumetric Optical Imaging of Tissue Microstructure for Grading of Dysplasia In Vivo
Thesis
application/pdf
Doctoral
Doctor of Philosophy
Publication
unknown
unknown
<Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="7fa0134c-8a1a-4c53-b2d7-5b2680dc2a32">
<Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843</Type>
<Title>Volumetric Optical Imaging of Tissue Microstructure for Grading of Dysplasia In Vivo</Title>
<PublishedIn>
<Publication>
</Publication>
</PublishedIn>
<PublicationDate>2023-06</PublicationDate>
<Authors>
<Author>
<DisplayName>Cannon, Taylor M.</DisplayName>
<Affiliation>
<OrgUnit>
</OrgUnit>
</Affiliation>
</Author>
</Authors>
<Editors>
</Editors>
<Publishers>
<Publisher>
<DisplayName>Massachusetts Institute of Technology</DisplayName>
<OrgUnit />
</Publisher>
</Publishers>
<License>https://rightsstatements.org/page/InC-EDU/1.0/</License>
<Abstract>Optical imaging offers unique advantages in medical diagnostics. In particular, high resolution, fast imaging speed, and strong depth penetration make optical coherence tomography (OCT) an attractive modality for non-perturbatively investigating structural changes in tissue that accompany disease progression on the microscale. Although clinical interpretation of OCT images is generally qualitative, the scattered light intensity signal underlying these images may be analyzed further to calculate sub-resolution sample properties, accessing additional functional information in tissue. Developing meaningful ways to compute and interpret these properties could enable earlier detection of structural disease-associated tissue changes, such as increases in sizes and densities of epithelial nuclei with the progression of esophageal dysplasia. In this thesis research, we investigate the application of novel signal processing methods and custom OCT hardware to uncover biomarkers of dysplasia based on these pathological changes in cell nuclei. Further, we apply our methods to evaluate patients during upper gastrointestinal endoscopy using a custom imaging device designed for enhanced sensitivity to these dysplastic changes, potentiating a more sensitive screening paradigm towards earlier detection of esophageal cancer.</Abstract>
<Access xmlns="http://purl.org/coar/access_right"
>
</Access>
</Publication>